Finance

Lists
Why is SMNR down 22,33%?
Dive Deeper
SMNR:OTCMKTS
Semnur Pharmaceuticals Inc
0,40 $
-22,33%
(-0,11) 1D
16 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SMNR...
Open
0,51 $
High
0,52 $
Low
0,39 $
Mkt. cap
91,20 млн
Avg. vol.
4,24 мың
Volume
772,00
52-wk high
23,00 $
52-wk low
0,13 $
Beta
-109,28
Shares outstanding
230,21 млн
No. of employees
5
Open
0,51 $
High
0,52 $
Low
0,39 $
Mkt. cap
91,20 млн
Avg. vol.
4,24 мың
Volume
772,00
52-wk high
23,00 $
52-wk low
0,13 $
Beta
-109,28
Shares outstanding
230,21 млн
No. of employees
5
News stories
From web sources and news partners
About Semnur Pharmaceuticals Inc
CEO-
Employees5
Founded2013
HeadquartersПало Альто, Калифорния, Америка Құрама Штаттары
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,14 млн
714,00 м.
1,27 млн
1,25 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
151,45 млн
5,44 млн
3,31 млн
2,98 млн
Operating expense
152,59 млн
6,16 млн
4,58 млн
4,22 млн
Total operating expenses
152,59 млн
6,16 млн
4,58 млн
4,22 млн
Operating income
-152,59 млн
-6,16 млн
-4,58 млн
-4,22 млн
Other non operating income
-
-
-
-
EBT including unusual items
-152,59 млн
-6,16 млн
-4,58 млн
-4,35 млн
EBT excluding unusual items
-152,59 млн
-6,16 млн
-4,58 млн
-4,35 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-152,59 млн
-6,16 млн
-4,58 млн
-4,35 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-123,00 м.
Net interest expenses
-
-
-
-123,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары